COVID-19 related multisystem inflammatory syndrome in children (MIS-C): A case series from Ethiopia

Tinsae, Alemayehu; Kaleab, Tesfaye; Selamawit, Tariku; Demeke, Mekonnen; Demessie Firew, Eden; Getachew Gebru, Caleb; Atle Benti, Natnael; Timsew, Anteneh; Mohammad Abdusemed, Yahya; Teklu, Nathan; Mahlet Gebrehiwot, Tolera; Karibian, Alan.
Ethiop. Med. j ; 61(2): 199-201, 2023. tables
Artículo en Inglés | AIM | ID: biblio-1427002

Documentos relacionados

  1. In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: A Brazilian cooperation.
  2. Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review.
  3. Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype.
  4. Presentation of cryopyrin-associated periodic fever syndrome as chronic, afebrile urticaria in a 12-month-old female.
  5. Subdural hemorrhage, macrocephaly, rash, and developmental delay in an infant: A pathogenic variant in NLRP3 causes CINCA/NOMID.
  6. Equally potent: Nlrp3 mutation in macrophages or neutrophils is sufficient to drive autoinflammation.
  7. AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review.
  8. Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood.
  9. Cryopyrin-associated periodic syndrome: a treatable genetic inflammatory condition.
  10. Lipids in inflammasome activation and autoinflammatory disorders.